Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Gene-Editing Tool Specifically Modifies RNA

By LabMedica International staff writers
Posted on 27 Mar 2018
A team of genomics researchers has isolated and characterized a novel form of the CRISPR gene editing system that specifically targets RNA rather than DNA.

CRISPR/Cas9 is regarded as the cutting edge of molecular biology technology. More...
CRISPRs (clustered regularly interspaced short palindromic repeats) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacterial virus or plasmid. Since 2013, the CRISPR/Cas9 system has been used in research for gene editing (adding, disrupting, or changing the sequence of specific genes) and gene regulation. By delivering the Cas9 enzyme and appropriate guide RNAs (sgRNAs) into a cell, the organism's genome can be cut at any desired location. The conventional CRISPR/Cas9 system is composed of two parts: the Cas9 enzyme, which cleaves the DNA molecule and specific RNA guides that shepherd the Cas9 protein to the target gene on a DNA strand.

Investigators at the Salk Institute for Biological Research (La Jolla, CA, USA) analyzed prokaryotic genome and metagenome sequences to identify uncharacterized families of RNA-guided, RNA-targeting CRISPR systems. Biochemical characterization and protein engineering of seven distinct orthologs generated a ribonuclease effector (CasRx) derived from the gut bacterium Ruminococcus flavefaciens XPD3002 with robust activity in human cells. CasRx-mediated knockdown exhibited high efficiency and specificity relative to RNA interference across diverse endogenous transcripts. In addition to high efficiency and specificity, CasRx was one of the most compact single-effector Cas enzymes and could be flexibly packaged into an adeno-associated virus for in in vivo delivery.

To demonstrate the potential clinical value of the CasRx system, the investigators used a viral vector to insert it into neuronal stem cells derived from a patient with the neurodegenerative disorder frontotemporal dementia (FTD). This disorder is characterized by an imbalance in the ratio of two forms of the tau protein. The inserted CasRx had been genetically engineered to target RNA sequences for the version of the tau protein that was in excess.

Results published in the March 15, 2018, online edition of the journal Cell revealed that CasRx was 80% effective in rebalancing the levels of tau protein to healthy levels.

"Bioengineers are like nature's detectives, searching for clues in patterns of DNA to help solve the mysteries of genetic diseases," said senior author Dr. Patrick Hsu, a Helmsley-Salk Fellow at the Salk Institute for Biological Research. "CRISPR has revolutionized genome engineering, and we wanted to expand the toolbox from DNA to RNA."

Related Links:
Salk Institute for Biological Research


New
Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Capillary Blood Collection Tube
IMPROMINI M3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AiPlex VAS for the MosaiQ platform is designed to help reduce time-to-diagnosis for patients with autoimmune vasculitis (Photo courtesy of AliveDx)

Novel Multiplex Assay Supports Diagnosis of Autoimmune Vasculitis

Autoimmune vasculitis and related conditions are difficult to diagnose quickly and accurately, often requiring multiple tests to confirm the presence of specific autoantibodies. Traditional methods can... Read more

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.